Anna Jerzak vel Dobosz

Learn More
BACKGROUND The development of accurate diagnostic methods in gastrointestinal stromal tumors (GISTs) and the introduction of imatinib (IM) therapy has focused attention on the factors influencing the(More)
  • 1